Natural history and outcome of neuroendocrine carcinoma of the cervix
- PMID: 26873865
- PMCID: PMC4844781
- DOI: 10.1016/j.ygyno.2016.02.008
Natural history and outcome of neuroendocrine carcinoma of the cervix
Abstract
Objective: Neuroendocrine carcinomas of the cervix (NECC) are rare and thought to be aggressive. We performed a population-based analysis to examine the natural history, treatment patterns and outcomes of women with NECC compared to squamous cell carcinoma (SCCC) and adenocarcinoma (AC) of the cervix.
Methods: The National Cancer Database (NCDB) was utilized to identify women with NECC, SCCC, and AC treated from 1998 to 2011. Clinical, demographic, and treatment characteristics were compared between the groups. The association between tumor histology and survival was examined using Kaplan-Meier analyses and multivariable Cox proportional hazards regression models.
Results: We identified 127,332 patients, including 1,896 (1.5%) with NECC and 101,240 (79.5%) with SCCC and 24,196 (19.0%) with AC. Patients with NECC were younger, more often white, commercially insured, and diagnosed with metastatic disease at presentation compared to women with SCCC. Patients with early-stage NECC were more likely to receive adjuvant chemotherapy and radiation after surgery (P<0.05 for both). In multivariable models stratified by stage and adjusted for clinical and demographic characteristics, the risk of death was higher for patients with NECC compared to SCCC for all stages of disease: stages IB-IIA (HR=2.96; 95% CI, 2.48-3.52), stages IIB-IVA (HR=1.70; 95% CI, 1.45-1.99) and stage IVB (HR=1.14; 95% CI, 0.91-1.43).
Conclusion: NECC are aggressive tumors associated with an increased risk of death. Survival is inferior for NECC compared to squamous cell tumors for women with both early and advanced stage disease.
Keywords: Cervical cancer; Cervical carcinoma; Cervix; Neuroendocrine carcinoma; Squamous cell carcinoma.
Copyright © 2016 Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors have no conflicts of interests.
Figures



References
-
- Albores-Saavedra J, Larraza O, Poucell S, Rodriguez Martinez HA. Carcinoid of the uterine cervix: additional observations on a new tumor entity. Cancer. 1976;38:2328–2342. - PubMed
-
- Scully RE, Aguirre P, DeLellis RA. Argyrophilia, serotonin, and peptide hormones in the female genital tract and its tumors. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists. 1984;3:51–70. - PubMed
-
- Miller B, Dockter M, el Torky M, Photopulos G. Small cell carcinoma of the cervix: a clinical and flow-cytometric study. Gynecologic oncology. 1991;42:27–33. - PubMed
-
- van Nagell JR, Jr, Donaldson ES, Parker JC, van Dyke AH, Wood EG. The prognostic significance of pelvic lymph node morphology in carcinoma of the uterine cervix. Cancer. 1977;39:2624–2632. - PubMed
-
- Chan JK, Loizzi V, Burger RA, Rutgers J, Monk BJ. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis. Cancer. 2003;97:568–574. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical